查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1477962

神經外科市場：依地區：全球產業分析、規模、佔有率、成長、趨勢，2024-2032 年預測

Neurosurgery Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 300 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究提供了一份全面的報告，全面分析了神經外科市場並詳細介紹了其全球前景。這份詳細的出版物提供了有關市場動態、趨勢、機會和課題的寶貴見解，並對其結構進行了全面概述。在獨家數據和統計的支持下，預測 2024 年至 2032 年神經外科市場的預期成長軌跡。

預計到2024年底，神經外科市場的全球收入將達到43.7億美元，以4.5%的複合年增長率穩定成長。預計到 2032 年底，這一軌跡將使市場規模成長至約 79 億美元。

重要見解

  • 神經外科市場規模（2024年）：43.7億美元
  • 預計市值（2032 年）：79 億美元
  • 全球市場成長率（2024-2032年複合年增長率）：4.5%

神經外科市場：調查範圍

神經外科包括旨在治療影響神經系統（包括大腦、脊髓和周圍神經）疾病的外科手術。神經外科市場包括用於診斷和治療神經系統疾病的各種手術技術、設備和技術。其主要業務包括神經刺激器、神經內視鏡系統、神經外科導航系統和神經介入設備。

市場成長的推動因素包括神經系統疾病盛行率的增加、手術技術和技術的進步以及微創手術需求的增加。此外，新興國家醫療費用的上漲、老年人口的增加以及醫療基礎設施的改善也促進了市場的擴張。

市場成長動力：

中風、癲癇、巴金森氏症和腦腫瘤等神經系統疾病的盛行率增加

神經影像技術的進步實現了準確的診斷和治療計劃

更多採用微創神經外科手術，減少患者不適並縮短復原時間

對治療慢性疼痛、運動障礙和精神疾病的神經刺激設備的需求不斷增長

擴大發展中地區的醫療基礎設施和專業神經外科中心的可用性

市場限制：

神經外科手術和設備的高昂成本限制了低收入地區的使用。

設備審批的嚴格監管要求延長了上市時間並增加了開發成本。

缺乏熟練的神經外科醫生和神經科醫生，特別是在農村和服務不足的地區。

對某些神經外科技術和設備的安全性和有效性的擔憂導致患者和醫療保健提供者猶豫不決。

市場機會：

神經外科在精神疾病、運動障礙和慢性疼痛疾病治療的新應用。

人工智慧 (AI) 和機器學習 (ML) 技術在神經影像和手術導航系統中的集成

產業利益相關者、研究機構和醫療保健提供者之間的合作，開發創新的神經外科解決方案。

遠距醫療和遠端監控服務的擴展改善了偏遠和服務不足地區獲得神經外科專家的機會

本報告解決的關鍵問題

  • 推動全球神經外科市場成長的關鍵因素是什麼？
  • 哪些神經外科技術和設備最受歡迎且採用率最高？
  • 技術進步如何改變神經外科市場的競爭格局？
  • 誰是對神經外科市場做出貢獻的主要公司？ 他們採取什麼策略來維持市場地位？
  • 全球神經外科市場有哪些新趨勢和未來前景？

目錄

第一章執行摘要

第二章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含什麼和不包含什麼

第 3 章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章 關鍵成功因素

  • 重大疾病流行病學
  • 產品採用/使用分析
  • 產品 USP/特點
  • 廠商主要促銷策略
  • 波特的分析
  • PESTLE分析
  • 價值鏈分析

第五章市場背景

  • 宏觀經濟因素
  • 預測變量 - 相關性和影響
  • 市場動態

第 6 章 COVID-19 危機分析

  • COVID-19 與影響分析
    • 依產品劃分的收入
    • 最終用戶收入
    • 國家收入
  • 2024年市場情景

第七章 全球神經外科市場需求（數量及規模）

  • 過去的市場（金額）分析，2019-2023
  • 當前和未來市場（價值）預測，2024-2032

第八章全球神經外科市場分析：依產品

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023
  • 當前和未來市場規模（金額）分析和預測，2024-2032
    • 神經介入裝置
      • 神經血管栓塞裝置
        • 栓塞彈簧圈
        • 液體栓塞系統
        • 血流導流支架
        • 動脈瘤夾
      • 神經血管線圈輔助裝置
        • 線圈輔助支架
        • 線圈輔助球囊
      • 神經血管取栓裝置
        • 支架取出裝置
        • 抽吸檢索器
      • 微導絲
      • 微導管
      • 支撐導管
      • 顱內支架
    • 神經內視鏡
      • 柔性神經內視鏡
      • 硬質神經內視鏡
    • 神經外科鑽孔機
      • 氣動神經外科鑽
      • 電動神經外科鑽
    • 放射外科系統
      • 線性加速放射外科系統
      • 伽瑪刀放射治療系統
    • 硬腦膜替代品
      • 生物硬腦膜替代品
      • 合成硬腦膜替代品
    • 神經外科消融裝置
      • MRI導引聚焦超音波系統
      • MRI導引雷射治療系統
      • MRI導引射頻消融系統
    • 神經外科器械
      • 組織牽開器
      • 鉗子
      • 頭架
      • 子宮頸電鍍系統
      • 穿孔器
  • 產品市場吸引力分析

第九章全球神經外科市場分析：依最終用戶分類

  • 簡介/主要發現
  • 過去的市場規模（金額）分析，2019-2023
  • 當前和未來市場規模（金額）分析和預測，2024-2032
    • 醫院
    • 門診手術中心
    • 專業神經學研究所
  • 最終用戶的市場吸引力分析

第10章全球神經外科市場分析：依地區

  • 介紹
  • 過去的市場規模（金額）分析，2019-2023
  • 當前和未來市場規模（金額）分析和預測，2024-2032
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲 (MEA)
  • 區域市場吸引力分析

第十一章 北美神經外科市場分析

第十二章拉丁美洲神經外科市場分析

第十三章歐洲神經外科市場分析

第14章南亞和太平洋地區神經外科市場分析

第十五章東亞神經外科市場分析

第十六章大洋洲神經外科市場分析

第十七章中東與非洲神經外科市場分析

第18章市場結構分析

  • 依公司層級進行市場分析
  • 主要參與者的市場佔有率分析
  • 市場存在分析

第 19 章 競爭分析

  • 比賽儀表板
  • 競爭標桿
  • 衝突詳情
    • Stryker Corp.
    • B. Braun Melsungen AG
    • Medtronic plc
    • DePuy Synthes
    • Boston Scientific
    • Terumo Corporation
    • KARL STORZ GmbH &Co KG
    • Integra LifeSciences
    • Penumbra Inc
    • Adeor Medical AG
    • Elekta
    • Clarus Medical
    • MACHIDA ENDOSCOPE CO., LTD.

第 20 章使用的假設和首字母縮略詞

第21章研究方法論

簡介目錄
Product Code: PMRREP4790

Persistence Market Research has conducted a thorough analysis of the Neurosurgery Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Neurosurgery Market spanning from 2024 to 2032.

The neurosurgery market's global revenue stood at US$ 4.37 billion by the close of 2024, projected to grow steadily with a compound annual growth rate (CAGR) of 4.5%. This trajectory is expected to propel the market to approximately US$ 7.9 billion by the conclusion of 2032.

Key Insights:

  • Neurosurgery Market Size (2024): US$ 4.37 billion
  • Projected Market Value (2032): US$ 7.9 billion
  • Global Market Growth Rate (CAGR 2024-2032): 4.5%

Neurosurgery Market - Report Scope:

Neurosurgery involves surgical procedures aimed at treating conditions affecting the nervous system, including the brain, spinal cord, and peripheral nerves. The neurosurgery market encompasses a wide range of surgical techniques, devices, and technologies used in the diagnosis and treatment of neurological disorders. Key segments include neurostimulation devices, neuroendoscopy systems, neurosurgical navigation systems, and neurointerventional devices.

Market growth is driven by factors such as the increasing prevalence of neurological disorders, advancements in surgical techniques and technologies, and growing demand for minimally invasive procedures. Additionally, rising healthcare expenditures, expanding geriatric population, and improving healthcare infrastructure in emerging economies contribute to market expansion.

Market Growth Drivers:

Increasing prevalence of neurological disorders such as stroke, epilepsy, Parkinson's disease, and brain tumors

Advancements in neuroimaging techniques, enabling accurate diagnosis and treatment planning

Growing adoption of minimally invasive neurosurgical procedures, reducing patient discomfort and recovery times

Rising demand for neurostimulation devices for the management of chronic pain, movement disorders, and psychiatric conditions

Expansion of healthcare infrastructure and the availability of specialized neurosurgical centers in developing regions

Market Restraints:

High cost associated with neurosurgical procedures and devices, limiting access in low-income regions

Stringent regulatory requirements for device approval, leading to extended time-to-market and higher development costs

Lack of skilled neurosurgeons and neurologists, particularly in rural and underserved areas

Concerns regarding the safety and efficacy of certain neurosurgical techniques and devices, leading to hesitancy among patients and healthcare providers

Market Opportunities:

Emerging applications of neurosurgery in the treatment of psychiatric disorders, movement disorders, and chronic pain conditions

Integration of artificial intelligence (AI) and machine learning (ML) technologies in neuroimaging and surgical navigation systems

Collaboration between industry stakeholders, research institutions, and healthcare providers to develop innovative neurosurgical solutions

Expansion of telemedicine and remote monitoring services, improving access to neurosurgical expertise in remote and underserved areas

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the neurosurgery market globally?
  • Which neurosurgical techniques and devices are experiencing the highest demand and adoption rates?
  • How are technological advancements reshaping the competitive landscape of the neurosurgery market?
  • Who are the key players contributing to the neurosurgery market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global neurosurgery market?

Competitive Intelligence and Business Strategy:

Leading players in the global neurosurgery market, including Medtronic plc, Stryker Corporation, Johnson & Johnson, and Integra LifeSciences Holdings Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced neurosurgical devices and technologies, catering to the evolving needs of patients and healthcare providers.

Collaborations with neurology and neurosurgery centers, academic institutions, and government agencies facilitate market access and technology adoption. Moreover, emphasis on physician training, patient education, and clinical research promotes evidence-based practice and improves patient outcomes in the rapidly evolving field of neurosurgery.

Key Companies Profiled

  • B. Braun Melsungen AG
  • Medtronic plc
  • DePuy Synthes
  • Boston Scientific
  • Stryker Corp.
  • Terumo Corporation
  • KARL STORZ GmbH & Co KG
  • Integra LifeSciences
  • Penumbra Inc
  • Adeor Medical AG
  • Elekta
  • Clarus Medical
  • MACHIDA ENDOSCOPE CO., LTD.

Key Segments Covered in Neurosurgery Industry Research

Neurosurgery Market by Product:

  • Neuro Interventional Devices
  • Neuroendoscopes
  • Neurosurgical Drills
  • Radiosurgery Systems
  • Dura Substitutes
  • Neurosurgery Instruments

Neurosurgery Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Neurological Institutes

Neurosurgery Market by Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Disease Epidemiology
  • 4.2. Product Adoption / Usage Analysis
  • 4.3. Product USPs / Features
  • 4.4. Key Promotional Strategies, By Manufacturers
  • 4.5. Porter's Analysis
  • 4.6. PESTLE Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Market GDP and Growth Outlook
    • 5.1.2. Global Assistive Devices Market Overview
    • 5.1.3. Medical Device Industry Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. GDP Growth Forecast
    • 5.2.2. Ageing Population
    • 5.2.3. Growing Prevalence of Neurologic Diseases
    • 5.2.4. Growing Healthcare Expenditure
    • 5.2.5. Shift Towards Minimally Invasive Procedures
    • 5.2.6. Growing Research Efforts
    • 5.2.7. Cost Impact
    • 5.2.8. Entries Of New Start-Up Companies In The Market
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Product
    • 6.1.2. Revenue By End User
    • 6.1.3. Revenue by Country
  • 6.2. 2024 Market Scenario

7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 8.3.1. Neuro Interventional Devices
      • 8.3.1.1. Neurovascular Embolization Devices
        • 8.3.1.1.1. Embolization Coils
        • 8.3.1.1.2. Liquid Embolic Systems
        • 8.3.1.1.3. Flow Diversion Stents
        • 8.3.1.1.4. Aneurysm Clips
      • 8.3.1.2. Neurovascular Coiling Assist Devices
        • 8.3.1.2.1. Coiling Assist Stents
        • 8.3.1.2.2. Coiling Assist Balloons
      • 8.3.1.3. Neurovascular Thrombectomy Devices
        • 8.3.1.3.1. Stent Retrievers
        • 8.3.1.3.2. Aspiration Retrievers
      • 8.3.1.4. Microguidewires
      • 8.3.1.5. Microcatheters
      • 8.3.1.6. Support Catheters
      • 8.3.1.7. Intracranial Stents
    • 8.3.2. Neuroendoscopes
      • 8.3.2.1. Flexible Neuroendoscopes
      • 8.3.2.2. Rigid Neuroendoscopes
    • 8.3.3. Neurosurgical Drills
      • 8.3.3.1. Pneumatic Neurosurgical Drills
      • 8.3.3.2. Electrical Neurosurgical Drills
    • 8.3.4. Radiosurgery Systems
      • 8.3.4.1. Linear Accelerator Radiosurgery Systems
      • 8.3.4.2. Gamma Knife Radiosurgery Systems
    • 8.3.5. Dura Substitutes
      • 8.3.5.1. Biological Dura Substitutes
      • 8.3.5.2. Synthetic Dura Substitutes
    • 8.3.6. Neurosurgical Ablation Devices
      • 8.3.6.1. MRI Guided Focused Ultrasound Systems
      • 8.3.6.2. MRI Guided Laser Therapy Systems
      • 8.3.6.3. MRI Guided RF Ablation Systems
    • 8.3.7. Neurosurgery Instruments
      • 8.3.7.1. Tissue Retractors
      • 8.3.7.2. Forceps
      • 8.3.7.3. Head Frames
      • 8.3.7.4. Cervical Plating systems
      • 8.3.7.5. Perforators
  • 8.4. Market Attractiveness Analysis By Product

9. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Specialized Neurological Institutes
  • 9.4. Market Attractiveness Analysis By End User

10. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By End User
  • 11.5. Market Trends
  • 11.6. Key Market Participants - Intensity Mapping
  • 11.7. Drivers and Restraints - Impact Analysis
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Neurosurgery Market
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Product
        • 11.8.1.2.2. By End User
    • 11.8.2. Canada Neurosurgery Market
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Product
        • 11.8.2.2.2. By End User

12. Latin America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Argentina
      • 12.3.1.3. Mexico
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Brazil Neurosurgery Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By End User
    • 12.8.2. Mexico Neurosurgery Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By End User
    • 12.8.3. Argentina Neurosurgery Market
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Product
        • 12.8.3.2.2. By End User

13. Europe Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Italy
      • 13.3.1.4. Spain
      • 13.3.1.5. UK
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Nordic Countries
      • 13.3.1.9. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Neurosurgery Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By End User
    • 13.8.2. Italy Neurosurgery Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By End User
    • 13.8.3. France Neurosurgery Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By End User
        • 13.8.3.2.3.
    • 13.8.4. Spain Neurosurgery Market
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Product
        • 13.8.4.2.2. By End User
    • 13.8.5. U.K. Neurosurgery Market
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Product
        • 13.8.5.2.2. By End User
    • 13.8.6. Benelux Union Neurosurgery Market
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Product
        • 13.8.6.2.2. By End User
    • 13.8.7. Nordic Countries Neurosurgery Market
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Product
        • 13.8.7.2.2. By End User
    • 13.8.8. Russia Neurosurgery Market
      • 13.8.8.1. Introduction
      • 13.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.8.2.1. By Product
        • 13.8.8.2.2. By End User

14. South Asia and Pacific Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. Indonesia
      • 14.3.1.3. Malaysia
      • 14.3.1.4. Thailand
      • 14.3.1.5. Rest of South Asia
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. India Neurosurgery Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
    • 14.8.2. Indonesia Neurosurgery Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
    • 14.8.3. Malaysia Neurosurgery Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By End User
    • 14.8.4. Thailand Neurosurgery Market
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By End User

15. East Asia Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Neurosurgery Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
    • 15.8.2. Japan Neurosurgery Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
    • 15.8.3. South Korea Neurosurgery Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User

16. Oceania Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Neurosurgery Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
    • 16.8.2. New Zealand Neurosurgery Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User

17. Middle East and Africa Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. Israel
      • 17.3.1.4. Northern Africa
      • 17.3.1.5. South Africa
      • 17.3.1.6. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Neurosurgery Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
    • 17.8.2. Turkey Neurosurgery Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
    • 17.8.3. North Africa Neurosurgery Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User
    • 17.8.4. South Africa Neurosurgery Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Stryker Corp.
      • 19.3.1.1. .Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Key Financials
      • 19.3.1.4. SWOT Analysis
      • 19.3.1.5. Key Developments
      • 19.3.1.6. Sales Footprint
      • 19.3.1.7. Strategy Overview
        • 19.3.1.7.1. Marketing Strategy
        • 19.3.1.7.2. Product Strategy
        • 19.3.1.7.3. Channel Strategy
    • 19.3.2. B. Braun Melsungen AG
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Key Financials
      • 19.3.2.4. SWOT Analysis
      • 19.3.2.5. Key Developments
      • 19.3.2.6. Sales Footprint
      • 19.3.2.7. Strategy Overview
        • 19.3.2.7.1. Marketing Strategy
        • 19.3.2.7.2. Product Strategy
        • 19.3.2.7.3. Channel Strategy
    • 19.3.3. Medtronic plc
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Key Financials
      • 19.3.3.4. SWOT Analysis
      • 19.3.3.5. Key Developments
      • 19.3.3.6. Sales Footprint
      • 19.3.3.7. Strategy Overview
        • 19.3.3.7.1. Marketing Strategy
        • 19.3.3.7.2. Product Strategy
        • 19.3.3.7.3. Channel Strategy
    • 19.3.4. DePuy Synthes
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Key Financials
      • 19.3.4.4. SWOT Analysis
      • 19.3.4.5. Key Developments
      • 19.3.4.6. Sales Footprint
      • 19.3.4.7. Strategy Overview
        • 19.3.4.7.1. Marketing Strategy
        • 19.3.4.7.2. Product Strategy
        • 19.3.4.7.3. Channel Strategy
    • 19.3.5. Boston Scientific
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Key Financials
      • 19.3.5.4. SWOT Analysis
      • 19.3.5.5. Key Developments
      • 19.3.5.6. Sales Footprint
      • 19.3.5.7. Strategy Overview
        • 19.3.5.7.1. Marketing Strategy
        • 19.3.5.7.2. Product Strategy
        • 19.3.5.7.3. Channel Strategy
    • 19.3.6. Terumo Corporation
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Key Financials
      • 19.3.6.4. SWOT Analysis
      • 19.3.6.5. Key Developments
      • 19.3.6.6. Sales Footprint
      • 19.3.6.7. Strategy Overview
        • 19.3.6.7.1. Marketing Strategy
        • 19.3.6.7.2. Product Strategy
        • 19.3.6.7.3. Channel Strategy
    • 19.3.7. KARL STORZ GmbH & Co KG
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Key Financials
      • 19.3.7.4. SWOT Analysis
      • 19.3.7.5. Key Developments
      • 19.3.7.6. Sales Footprint
      • 19.3.7.7. Strategy Overview
        • 19.3.7.7.1. Marketing Strategy
        • 19.3.7.7.2. Product Strategy
        • 19.3.7.7.3. Channel Strategy
    • 19.3.8. Integra LifeSciences
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Key Financials
      • 19.3.8.4. SWOT Analysis
      • 19.3.8.5. Key Developments
      • 19.3.8.6. Sales Footprint
      • 19.3.8.7. Strategy Overview
        • 19.3.8.7.1. Marketing Strategy
        • 19.3.8.7.2. Product Strategy
        • 19.3.8.7.3. Channel Strategy
    • 19.3.9. Penumbra Inc
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Key Financials
      • 19.3.9.4. SWOT Analysis
      • 19.3.9.5. Key Developments
      • 19.3.9.6. Sales Footprint
      • 19.3.9.7. Strategy Overview
        • 19.3.9.7.1. Marketing Strategy
        • 19.3.9.7.2. Product Strategy
        • 19.3.9.7.3. Channel Strategy
    • 19.3.10. Adeor Medical AG
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Key Financials
      • 19.3.10.4. SWOT Analysis
      • 19.3.10.5. Key Developments
      • 19.3.10.6. Sales Footprint
      • 19.3.10.7. Strategy Overview
        • 19.3.10.7.1. Marketing Strategy
        • 19.3.10.7.2. Product Strategy
        • 19.3.10.7.3. Channel Strategy
    • 19.3.11. Elekta
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Key Financials
      • 19.3.11.4. SWOT Analysis
      • 19.3.11.5. Key Developments
      • 19.3.11.6. Sales Footprint
      • 19.3.11.7. Strategy Overview
        • 19.3.11.7.1. Marketing Strategy
        • 19.3.11.7.2. Product Strategy
        • 19.3.11.7.3. Channel Strategy
    • 19.3.12. Clarus Medical
      • 19.3.12.1. Overview
      • 19.3.12.2. Product Portfolio
      • 19.3.12.3. Key Financials
      • 19.3.12.4. SWOT Analysis
      • 19.3.12.5. Key Developments
      • 19.3.12.6. Sales Footprint
      • 19.3.12.7. Strategy Overview
        • 19.3.12.7.1. Marketing Strategy
        • 19.3.12.7.2. Product Strategy
        • 19.3.12.7.3. Channel Strategy
    • 19.3.13. MACHIDA ENDOSCOPE CO., LTD.
      • 19.3.13.1. Overview
      • 19.3.13.2. Product Portfolio
      • 19.3.13.3. Key Financials
      • 19.3.13.4. SWOT Analysis
      • 19.3.13.5. Key Developments
      • 19.3.13.6. Sales Footprint
      • 19.3.13.7. Strategy Overview
        • 19.3.13.7.1. Marketing Strategy
        • 19.3.13.7.2. Product Strategy
        • 19.3.13.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology